Literature DB >> 21430644

The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine.

Elizabeth Cahir1, Katie Pillidge, John Drago, Andrew J Lawrence.   

Abstract

Here we utilize a mouse line with a targeted deletion of the α4 subunit (α4-/- mice), to investigate the role of α4* nAChRs in reinforcing and locomotor effects of nicotine. Within a conditioned place preference paradigm, both α4-/- mice and wild-type (WT) littermates showed a similar place preference to nicotine (0.5 mg/kg i.p.) conditioning. When assessed for operant intravenous self-administration of nicotine (0.05 mg/kg/infusion), α4-/- mice did not differ from their WT littermates in self-administration behavior. To further examine a modulatory role for α4* nAChRs in the reinforcing effects of nicotine, a transgenic mouse with a point mutation of the α4 subunit (α4-S248F) that renders increased sensitivity to low dose nicotine, was assessed for nicotine self-administration over a range of doses. At higher doses examined (0.05 and 0.07 mg/kg/infusion) there was no difference in intravenous nicotine self-administration; however, when mice were offered a lower dose of nicotine (0.03 mg/kg/infusion), α4-S248F mice showed greater nicotine intake than controls. Acute administration of 0.5 mg/kg nicotine caused significant locomotor depression in WT mice but α4-/- mice instead showed significant hyperactivity. Following chronic, intermittent administration of this dose of nicotine only WT mice displayed significant tolerance. Analogous experiments utilizing administration of the nicotinic antagonist mecamylamine in WT mice confirmed a dissociation between the putative nicotinic receptor subtypes required for mediating psychomotor and reinforcing effects of nicotine. These data demonstrate a necessary role for α4* nAChRs in the locomotor depressant effect of nicotine but not the reinforcing effects that support ongoing self-administration of nicotine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430644      PMCID: PMC3096818          DOI: 10.1038/npp.2011.35

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  60 in total

1.  Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.

Authors:  L M Marubio; A M Gardier; S Durier; D David; R Klink; M M Arroyo-Jimenez; J M McIntosh; F Rossi; N Champtiaux; M Zoli; J-P Changeux
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

2.  Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.

Authors:  Layla Azam; Ursula H Winzer-Serhan; Yiling Chen; Frances M Leslie
Journal:  J Comp Neurol       Date:  2002-03-12       Impact factor: 3.215

3.  Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes.

Authors:  R L Papke; P R Sanberg; R D Shytle
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

4.  Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion.

Authors:  N le Novère; M Zoli; C Léna; R Ferrari; M R Picciotto; E Merlo-Pich; J P Changeux
Journal:  Neuroreport       Date:  1999-08-20       Impact factor: 1.837

Review 5.  Nicotine self-administration in animals as a dependence model.

Authors:  W A Corrigall
Journal:  Nicotine Tob Res       Date:  1999-03       Impact factor: 4.244

6.  Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse.

Authors:  S A Ross; J Y Wong; J J Clifford; A Kinsella; J S Massalas; M K Horne; I E Scheffer; I Kola; J L Waddington; S F Berkovic; J Drago
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

7.  Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation.

Authors:  D Debruyne; F Sobrio; A Hinschberger; R Camsonne; A Coquerel; L Barré
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

8.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

9.  Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.

Authors:  Christie D Fowler; Qun Lu; Paul M Johnson; Michael J Marks; Paul J Kenny
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

10.  Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.

Authors:  Nicolas Champtiaux; Zhi-Yan Han; Alain Bessis; Francesco Mattia Rossi; Michele Zoli; Lisa Marubio; J Michael McIntosh; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

View more
  18 in total

Review 1.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

2.  Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.

Authors:  Sarah S Sanjakdar; Pretal P Maldoon; Michael J Marks; Darlene H Brunzell; Uwe Maskos; J Michael McIntosh; M Scott Bowers; M Imad Damaj
Journal:  Neuropsychopharmacology       Date:  2014-07-18       Impact factor: 7.853

3.  Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.

Authors:  Alycia M Lee; Adrian C Arreola; Blake A Kimmey; Heath D Schmidt
Journal:  Behav Brain Res       Date:  2014-08-14       Impact factor: 3.332

Review 4.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 5.  Recent advances in gene manipulation and nicotinic acetylcholine receptor biology.

Authors:  Anne Tammimäki; William J Horton; Jerry A Stitzel
Journal:  Biochem Pharmacol       Date:  2011-06-16       Impact factor: 5.858

Review 6.  Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.

Authors:  Luis M Tuesta; Christie D Fowler; Paul J Kenny
Journal:  Biochem Pharmacol       Date:  2011-06-29       Impact factor: 5.858

Review 7.  Unraveling the neurobiology of nicotine dependence using genetically engineered mice.

Authors:  Astrid K Stoker; Athina Markou
Journal:  Curr Opin Neurobiol       Date:  2013-03-29       Impact factor: 6.627

8.  Rats are the smart choice: Rationale for a renewed focus on rats in behavioral genetics.

Authors:  Clarissa C Parker; Hao Chen; Shelly B Flagel; Aron M Geurts; Jerry B Richards; Terry E Robinson; Leah C Solberg Woods; Abraham A Palmer
Journal:  Neuropharmacology       Date:  2013-06-18       Impact factor: 5.250

9.  Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).

Authors:  Elizabeth Watterson; Alexander Spitzer; Lucas R Watterson; Ryan J Brackney; Arturo R Zavala; M Foster Olive; Federico Sanabria
Journal:  Behav Brain Res       Date:  2016-06-27       Impact factor: 3.332

Review 10.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.